A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway
Open Access
- 30 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Cell International
- Vol. 21 (1), 1-10
- https://doi.org/10.1186/s12935-021-01973-1
Abstract
Multiple myeloma (MM) is a highly aggressive and incurable clonal plasma cell disease with a high rate of recurrence. Thus, the development of new therapies is urgently needed. DCZ0805, a novel compound synthesized from osalmide and pterostilbene, has few observed side effects. In the current study, we intend to investigate the therapeutic effects of DCZ0805 in MM cells and elucidate the molecular mechanism underlying its anti-myeloma activity. We used the Cell Counting Kit-8 assay, immunofluorescence staining, cell cycle assessment, apoptosis assay, western blot analysis, dual-luciferase reporter assay and a tumor xenograft mouse model to investigate the effect of DCZ0805 treatment both in vivo and in vitro. The results showed that DCZ0805 treatment arrested the cell at the G0/G1 phase and suppressed MM cells survival by inducing apoptosis via extrinsic and intrinsic pathways. DCZ0805 suppressed the NF-κB signaling pathway activation, which may have contributed to the inhibition of cell proliferation. DCZ0805 treatment remarkably reduced the tumor burden in the immunocompromised xenograft mouse model, with no obvious toxicity observed. The findings of this study indicate that DCZ0805 can serve as a novel therapeutic agent for the treatment of MM.Keywords
Funding Information
- National Natural Science Foundation of China (81670194, 81870158, 81900212)
- National Major Science and Technology Projects of China (2018ZX09711002)
This publication has 28 references indexed in Scilit:
- Apoptosis in cancer: from pathogenesis to treatmentJournal of Experimental & Clinical Cancer Research, 2011
- Oncogenic Activation of NF- BCold Spring Harbor Perspectives in Biology, 2010
- Evasion of Apoptosis as a Cellular Stress Response in CancerInternational Journal of Cell Biology, 2010
- The NF- B Family of Transcription Factors and Its RegulationCold Spring Harbor Perspectives in Biology, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB–regulated antiapoptotic and cell survival gene products in human multiple myeloma cellsBlood, 2006
- Transcriptional regulation via the NF-κB signaling moduleOncogene, 2006
- Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applicationsBlood, 2002
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983